References
<A NAME="RG35003ST-1A">1a</A>
Fisher LE.
Rosenkranz RP.
Clark RD.
Muchowski JM.
McClelland DL.
Michel A.
Caroon JM.
Galezzi E.
Eglen R.
Whiting RL.
Bioorg. Med. Chem. Lett.
1995,
5:
2371
<A NAME="RG35003ST-1B">1b</A>
Sonesson C.
Wikström H.
Smith MW.
Svensson K.
Carlsson A.
Waters N.
Bioorg. Med. Chem. Lett.
1997,
7:
241
<A NAME="RG35003ST-1C">1c</A>
Gerasimov M.
Marona-Lewicka D.
Kurrasch-Orbaugh DM.
Qandil AM.
Nichols DE.
J. Med. Chem.
1999,
42:
4257
<A NAME="RG35003ST-1D">1d</A>
Ahn KH.
Lee SJ.
Lee C.-H.
Hong CY.
Park TK.
Bioorg. Med. Chem. Lett.
1999,
9:
1379
<A NAME="RG35003ST-1E">1e</A> A series of nine papers on the antinociceptive activity of various substituted
3-arylpyrrolidines has been published by a research group from Parke Davis between
1961 and 1973 in J. Med. Chem., the last one being:
Bowman RE.
Collier HOJ.
Lockhart IM.
Schneider C.
Webb NE.
Wright M.
J. Med. Chem.
1973,
16:
1181
<A NAME="RG35003ST-2A">2a</A>
Elliott RL.
Ryther KB.
Anderson DJ.
Piattoni-Kaplan M.
Kuntzweiler TA.
Donnelly-Roberts D.
Arneric SP.
Holladay MW.
Bioorg. Med. Chem. Lett.
1997,
7:
2703
<A NAME="RG35003ST-2B">2b</A>
Kim KH.
Lin N.-H.
Anderson DJ.
Bioorg. Med. Chem.
1996,
4:
2211
<A NAME="RG35003ST-2C">2c</A>
Guzikowski AP.
Tamiz AP.
Acosta-Burruel M.
Hong-Bae S.
Cai SX.
Hawkinson JE.
Keana JFW.
Kesten SR.
Shipp CT.
Tran M.
Whittemore ER.
Woodward RM.
Wright JL.
Zhou Z.-L.
J. Med. Chem.
2000,
43:
984
<A NAME="RG35003ST-3A">3a</A>
Basha FZ.
DeBernardis JF.
Pure Appl. Chem.
1994,
66:
2201
<A NAME="RG35003ST-3B">3b</A>
Enyedy IJ.
Zaman WA.
Sakamuri S.
Kozikowski AP.
Johnson KM.
Wang SM.
Bioorg. Med. Chem. Lett.
2001,
11:
1113
<A NAME="RG35003ST-4A">4a</A>
Wallén EAA.
Christiaans JAM.
Saario SM.
Forsberg MM.
Venalainen JI.
Paso HM.
Mannisto PT.
Gynther J.
Bioorg. Med. Chem.
2002,
10:
2199
<A NAME="RG35003ST-4B">4b</A>
Feldman PL.
Brackeen MF.
Cowan DJ.
Marron BE.
Schoenen FJ.
Stafford JA.
Suh EM.
Domanico PL.
Rose D.
Leesnitzer MA.
Brawley ES.
Strickland AB.
Verghese MW.
Connolly KM.
Bateman-Fite R.
Noel LS.
Sekut L.
Stimpson SA.
J. Med. Chem.
1995,
38:
1505
For reviews, see:
<A NAME="RG35003ST-5A">5a</A>
Pichon M.
Figadère B.
Tetrahedron: Asymmetry
1996,
7:
927
<A NAME="RG35003ST-5B">5b</A>
1,3-Dipolar Cycloaddition Chemistry
Padwa A.
Wiley;
New York:
1984.
<A NAME="RG35003ST-5C">5c</A>
Pearson WH.
Stoy P.
Synlett
2003,
903
<A NAME="RG35003ST-5D">5d</A> For recent examples, see:
Tietze LF.
Evers H.
Töpken E.
Helv. Chim. Acta
2002,
85:
4200
<A NAME="RG35003ST-5E">5e</A>
Casas J.
Grigg R.
Nájera C.
Sansano JM.
Eur. J. Org. Chem.
2001,
1971
<A NAME="RG35003ST-5F">5f</A>
Davis AS.
Gates NJ.
Lindsay KB.
Tang M.
Pyne SG.
Synlett
2004,
49
<A NAME="RG35003ST-5G">5g</A>
Mota AJ.
Chiaroni A.
Langlois N.
Eur. J. Org. Chem.
2003,
4187
See for example:
<A NAME="RG35003ST-6A">6a</A>
Pearson WH.
Szura DP.
Postich MJ.
J. Am. Chem. Soc.
1992,
114:
1329
<A NAME="RG35003ST-6B">6b</A>
Zimmer R.
Hoffmann M.
Reissig H.-U.
Chem. Ber.
1992,
125:
2243
<A NAME="RG35003ST-6C">6c</A>
Pulz R.
Al-Harrasi A.
Reissig H.-U.
Org. Lett.
2002,
4:
2353
<A NAME="RG35003ST-6D">6d</A>
Vanucci C.
Brusson X.
Verdel V.
Zana F.
Dhimane H.
Lhommet G.
Tetrahedron Lett.
1995,
36:
2971
<A NAME="RG35003ST-6E">6e</A>
Lorthiois E.
Marek I.
Normant JF.
Tetrahedron Lett.
1997,
38:
89
<A NAME="RG35003ST-6F">6f</A>
Broka CA.
Shen T.
J. Am. Chem. Soc.
1989,
111:
2981
<A NAME="RG35003ST-6G">6g</A>
Coldham I.
J. Chem. Soc., Perkin Trans. 1
1993,
1275
<A NAME="RG35003ST-7">7</A>
Seebach D.
Angew. Chem., Int. Ed. Engl.
1979,
18:
239 ; Angew. Chem. 1979, 91, 259
<A NAME="RG35003ST-8">8</A>
Meyer N.
Opatz T.
Synlett
2003,
1427
<A NAME="RG35003ST-9A">9a</A>
Tsuge O.
Ueno K.
Kanemasa S.
Yorozu K.
Bull. Chem. Soc. Jpn.
1987,
60:
3347
<A NAME="RG35003ST-9B">9b</A>
Tsuge O.
Kanemasa S.
Yorozu K.
Ueno K.
Bull. Chem. Soc. Jpn.
1987,
60:
3359
<A NAME="RG35003ST-9C">9c</A>
Tsuge O.
Ueno K.
Kanemasa S.
Yorozu K.
Bull. Chem. Soc. Jpn.
1986,
59:
1809
<A NAME="RG35003ST-9D">9d</A> See also:
Roux-Schmitt MC.
Croisat D.
Seyden-Penne J.
Wartski L.
Cossentini M.
Pol. J. Chem.
1996,
70:
325
<A NAME="RG35003ST-9E">9e</A>
Opio JO.
Labidalle S.
Galons H.
Miocque M.
Synth. Commun.
1991,
21:
1743
<A NAME="RG35003ST-10">10</A>
General Procedure for the Preparation of α-(Alkylideneamino)nitriles 3a-c: To a solution of the aminonitrile (10 mmol) in dry CH2Cl2 (20 mL) were added MgSO4 (1.1 equiv) and the aldehyde (1.1 equiv). The suspension was stirred overnight. The
MgSO4 was filtered off and the organic phase was partitioned between a sat. NaHCO3 solution and CH2Cl2. The organic layer was dried over Na2SO4 and the solvent was evaporated in vacuo. Recrystallization yielded the pure imines.
In the case of products 3a and 3b, aminoacetonitrile sulfate was used and 1 equiv of Et3N was added to the reaction mixture.
<A NAME="RG35003ST-11">11</A>
Rodima T.
Kaljurand I.
Pihl A.
Mäemets V.
Leito I.
Koppel IA.
J. Org. Chem.
2002,
67:
1873
<A NAME="RG35003ST-12A">12a</A>
Tatsukawa A.
Kawatake K.
Kanemasa S.
Rudzi
ski JM.
J. Chem. Soc., Perkin Trans. 2
1994,
2525
<A NAME="RG35003ST-12B">12b</A>
Domingo LR.
J. Org. Chem.
1999,
64:
3922
<A NAME="RG35003ST-13">13</A>
General Procedure for the Preparation of Pyrrolidines 8a-g: To a solution of the α-(alkylideneamino)nitrile (1.45 mmol) in THF (5 mL) was added
a solution of DBU (1.59 mmol, 1.1 equiv) in THF (2 mL) under argon at r.t. After addition
of a solution of methyl vinyl ketone (1.59 mmol, 1.1 equiv) in THF (3 mL), the mixture
was stirred for 90 min. The reaction was stopped by addition of a mixture of EtOH
(87 mmol, 60 equiv) and HOAc (11.6 mmol, 8 equiv). After NaBH3CN (5.8 mmol, 4 equiv) was added, the mixture was stirred at r.t. overnight. The reaction
mixture was washed twice with 1 N NaOH and the combined aqueous phases were reextracted
with EtOAc. The combined organic layers were extracted three times with 1 N HCl and
the combined aqueous phases were made alkaline by addition of NaOH. Extraction with
CH2Cl2, drying over Na2SO4 and evapora-tion of the solvent in vacuo gave a crude product, which was further
purified by column chromatography, preparative TLC or HPLC if necessary. Note: Compounds
8f and 8g were too lipophilic for an efficient extraction with 1 N HCl. They were directly
purified by chromatographic methods.
<A NAME="RG35003ST-14">14</A>
Under identical conditions, compounds 3a and 3b could not be reacted cleanly with α,β-unsaturated aldehydes.
<A NAME="RG35003ST-15">15</A>
Spectroscopic Data of Compound cis
-8e: 1H NMR (400 MHz, CDCl3): δ = 7.28-7.21 (m, 2 H, Ph), 7.19-7.10 (m, 3 H, Ph), 6.92 (d, 1 H, J
2
′
,6
′ = 1.8 Hz, H-2′), 6.90 (dd, 1 H, J
5
′
,6
′ = 8.1 Hz, J
2
′
,6
′ = 1.8 Hz, H-6′), 6.83 (d, 1 H, J
5
′
,6
′ = 8.1 Hz, H-5′), 3.90, 3.88 (2 s, 6 H, OCH3), 3.81 [d, 1 H, J = 14.1 Hz, CH2C6H3 (OMe)2], 3.75 [d, 1 H, J = 14.1 Hz, CH2C6H3 (OMe)2], 2.93-2.81 (m, 2 H, CH2Ph, H-2), 2.74-2.60 (m, 1 H, H-5), 2.38 (dd, 1 H, J
gem = 12.4 Hz, J
vic = 9.2 Hz, CH2Ph), 1.81-1.70 (m, 1 H, H-4a), 1.67-1.44 (m, 2 H, H-3a, H-3b), 1.42-1.30 (m, 1 H,
H-4b), 1.07 (d, 3 H, J = 6.0 Hz, CH3). Irradiation (transient NOE) at δ = 2.68 ppm (H-5) enhances the signals at δ = 6.90
ppm (H-6′, 0.8%), 6.83 ppm (H-5′, 0.2%), 3.81 ppm [CH2C6H3 (OMe)2, 1.1%], 3.75 ppm [CH2C6H3 (OMe)2, 1.0%], 2.83 ppm (H-2, 0.6%), 1.72 ppm (H-4a, 2.2%), 1.55 ppm (H-3, 0.8%), 1.35 ppm
(H-4b, 0.6%), 1.07 ppm (CH3, 1.1%). 13C NMR (100.6 MHz, CDCl3): δ = 148.60, 147.87 (C-3′, C-4′), 140.30 (C-1 Ph), 137.28 (C-1′), 129.18, 128.08,
125.77 (Ph), 121.14 (C-6′), 112.56 (C-2′), 110.65 (C-5′), 66.11 (C-2), 60.09 (C-5),
56.28 [CH2C6H3 (OMe)2], 55.85 (OCH3), 42.46 (CH2Ph), 31.55 (C-4), 28.80 (C-3), 20.80 (CH3).
Spectroscopic Data of Compound trans
-8e: 1H NMR (400 MHz, CDCl3): δ = 7.26-7.20 (m, 2 H, Ph), 7.18-7.12 (m, 1 H, Ph), 7.05 (d, 2 H, J = 7 Hz, H-2, H-6 Ph), 6.98 (br s, 1 H, H-2′), 6.92 (dd, 1 H, J
5
′
,6
′ = 8.1 Hz, J
2
′
,6
′= 1.3 Hz, H-6′), 6.83 (d, 1 H, J
5
′
,6
′ = 8.1 Hz, H-5′), 3.92 [d, 1 H, J = 13.6 Hz, CH2-C6H3 (OMe)2], 3.90, 3.89 (2 s, 6 H, OCH3), 3.62 [d, 1 H, J = 13.6 Hz, CH2C6H3(OMe)2], 3.17-3.05 (m, 2 H, H-2, H-5), 2.96 (dd, 1 H, J
gem = 12.9 Hz, J
vic = 3.5 Hz, CH2Ph), 2.36 (dd, 1 H, Jgem = 12.9 Hz, J = 10.0 Hz, CH2Ph), 2.05-1.92 (m, 1 H, H-4a), 1.83-1.70 (m, 1 H, H-3a), 1.56-1.46 (m, 1 H, H-3b),
1.44-1.33 (m, 1 H, H-4b), 0.99 (d, 3 H, J = 6.2 Hz, CH3). 13C NMR (100 MHz, CDCl3): δ = 148.87, 147.69 (C-3′, C-4′); 140.49 (C-1 Benzyl), 136.52 (C-1′), 129.26, 128.12,
125.67 (Benzyl); 120.35 (C-6′); 111.72 (C-2′); 110.71 (C-5′); 61.91 (C-2); 55.89 (OCH3); 55.40 (C-5); 51.71 [CH2C6H3(OMe)2]; 37.63 (CH2Ph); 30.77 (C-4); 27.55 (C-3); 16.76 (CH3).
<A NAME="RG35003ST-16A">16a</A>
van der Werf A.
Kellogg RM.
Tetrahedron Lett.
1991,
32:
3727
<A NAME="RG35003ST-16B">16b</A>
Kanemasa K.
Uchida O.
Wada E.
J. Org. Chem.
1990,
55:
4411
<A NAME="RG35003ST-16C">16c</A>
Alvarez-Ibarra C.
Csákӱ AG.
Maroto M.
Quiroga ML.
J. Org. Chem.
1995,
60:
6700
<A NAME="RG35003ST-17">17</A>
Scott WL.
Alsina J.
O’Donnell MJ.
J. Comb. Chem.
2003,
5:
684
<A NAME="RG35003ST-18A">18a</A>
O’Donnell MJ.
Bennett WD.
Wu S.
J. Am. Chem. Soc.
1989,
111:
2353
<A NAME="RG35003ST-18B">18b</A> For a review, see:
O’Donnell MJ.
Aldrichimica Acta
2001,
34:
3